Comparison of PRP versus corticosteroid (triamcinolone) Intralesional Injection in the Treatment of Chronic Plantar Fasciitis
Authors/Creators
- 1. Senior Resident, Department of Orthopaedics, Nalanda Medical College and Hospital, Agam Kuaan, Patna
- 2. Senior Resident, Department of Orthopaedics, RD Gardi Medical College, Ujjain MP
- 3. Junior Consultant, Centre for Bone and Joints, BCM Kokilaben Dhirubhai Ambani Hospital, Indore, MP
- 4. Post-Graduate Student in Master of Physiotherapy, Trident College of Education
- 5. Senior Resident, Department of Dermatology, RD Gardi Medical College and RC, Ujjain MP
Description
Background: Plantar fasciitis is defined as localized inflammation and degeneration of the plantar aponeurosis. Heel pain is the most common reason for presentation.” Approximately 10% of the population will experience heel pain in their life. Many methods have already been tried for treating plantar fasciitis, including rest, night splints, Nonsteroidal anti-inflammatory drugs (NSAIDs), foot orthosis, stretching exercises, extracorporeal shock wave therapy, local injection of corticosteroids, and platelet-rich plasma (PRP) therapy has also been used with variable success. Material and Methods: We conducted the study in the Department of Orthopedics and Traumatology at Nalanda Medical College and Hospital, Agam Kuaan, Patna, The study is based purely on clinical observations so no specific investigations were done for outcome analysis. The study was conducted for a total duration of 24 months with a minimum follow-up of 6 months. A total of 60 patients were included in the study. Patients were separated into PRP and steroid groups of 30 subjects each. Results: In our study 60 patients with an average age of 43.6 years. Female to Male ratio is 2.3:1 approx. There was a female preponderance in our study. The majority of the patients were housewives (heavy physical workload). The PRP group had significantly higher mean AFAS and VAS scores at follow-up than the steroid group (p<0.001) There were no complications in 56 patients, 4 patients had a fever, and the patient was given antipyretics and antibiotics for the same and was settled. Conclusion: PRP injection is an effective and well-tolerated alternative to corticosteroid injection in the management of chronic plantar fasciitis with the added advantage of almost no side effects due to its biological nature and better patient compliance. Furthermore, PRP has added analgesic and antimicrobial properties.
Abstract (English)
Background: Plantar fasciitis is defined as localized inflammation and degeneration of the plantar aponeurosis. Heel pain is the most common reason for presentation.” Approximately 10% of the population will experience heel pain in their life. Many methods have already been tried for treating plantar fasciitis, including rest, night splints, Nonsteroidal anti-inflammatory drugs (NSAIDs), foot orthosis, stretching exercises, extracorporeal shock wave therapy, local injection of corticosteroids, and platelet-rich plasma (PRP) therapy has also been used with variable success. Material and Methods: We conducted the study in the Department of Orthopedics and Traumatology at Nalanda Medical College and Hospital, Agam Kuaan, Patna, The study is based purely on clinical observations so no specific investigations were done for outcome analysis. The study was conducted for a total duration of 24 months with a minimum follow-up of 6 months. A total of 60 patients were included in the study. Patients were separated into PRP and steroid groups of 30 subjects each. Results: In our study 60 patients with an average age of 43.6 years. Female to Male ratio is 2.3:1 approx. There was a female preponderance in our study. The majority of the patients were housewives (heavy physical workload). The PRP group had significantly higher mean AFAS and VAS scores at follow-up than the steroid group (p<0.001) There were no complications in 56 patients, 4 patients had a fever, and the patient was given antipyretics and antibiotics for the same and was settled. Conclusion: PRP injection is an effective and well-tolerated alternative to corticosteroid injection in the management of chronic plantar fasciitis with the added advantage of almost no side effects due to its biological nature and better patient compliance. Furthermore, PRP has added analgesic and antimicrobial properties.
Files
IJTPR,Vol14,Issue3,Article32.pdf
Files
(319.7 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:21885854f23e507cacd44a5f0b3426a1
|
319.7 kB | Preview Download |
Additional details
Dates
- Accepted
-
2024-02-26
Software
References
- League AC. Current concepts review: plantar fasciitis. Foot Ankle Int 2008; 29:358-66. 2. Kajikawa Y, Morihara T, Sakamoto H, et al. Platelet-rich plasma enhances the initial mobilization of circulation-derived cells for tendon healing. J Cell Physiol. 2008; 215:837- 845. 3. Kon E, Filardo G, Delcongliano M, et al. Platelet-rich plasma: new clinical application: a pilot study for treatment of jumper's knee. Injury. 2009; 40:598-603. 4. Lopez-Gavito E, Gomez-Carlin LA, ParraTellez P, et al. Platelet-rich plasma for managing calcaneus tendon tendinopathy and plantar fasciitis. Acta Ortop Mex. 2011; 25:380-385. 5. Lim AT, How CH, Tan B. Management of plantar fasciitis in the outpatient setting. Singapore Med J 2016; 57:168-70. 6. O'Malley MJ, Vosseller JT, GuY. Successful use of platelet-rich plasma for chronic plantar fasciitis. TSS J 2013; 9:129-33. 7. Yang WY, Han YH, Cao XW, Pan JK, Zeng LF, Lin JI, et al. Platelet-rich plasma as a treatment for plantar fasciitis: A meta-analysis of randomized controlled trials. Medicine (Baltimore) 2017; 96:08475. 8. Cheung IT, et al. Consequences of partial and total plantar fascial release: a finite element study. Foot Ankle Int. 2006; 27:125-132. 9. Hogan KA, Webb D, Shereff M. Endoscopic plantar fascia release. Foot Ankle Int. 2004; 25:875-881. 10. Toomey EP. Plantar heel pain. Foot Ankle Clin. 2009; 14: 229-245. 11. Hall MP, Brand PA, Meislin RJ, et al. Plateletrich plasma: current concepts and application in sports medicine. J Am Acad Orthop Surg. 2009; 17:602-609. 12. Anitua E, Sanchez M, Nurden AT, et al. Reciprocal actions of platelet-secreted TGFbeta 1 on the production of VEGF and HGF by human tendon cells. Plast Reconstr Surg. 2007; 119:950-959. 13. Anita E, Andia I, Sanchez M, et al. Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture. J Orthop Res. 2005;23:281-286. 14. McCarrel T, Fornier L. Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression. J Orthop Res. 2009; 27:1033-1042. 15. Virchenko O, Aspenberg P. How can one platelet injection after tendon injury lead to a stronger tendon after 4 weeks, The interplay between early regeneration and mechanical stimulation. Acta Orthop. 2006; 77:806-812. 16. Deghedy A, Hamid M, Helal A, El-Sherif S, Latief H. Platelet-rich plasma in the treatment of plantar fasciitis: Randomized doubleblinded placebo-controlled study. Journal of Applied Clinical Pathology.2019:2:1. 17. Martinelli N, Marinozzi A, Cari S, Trovato U, Bianchi A, Denaro V. Platelet-rich plasma injections for chronic plantar fasciitis. Int Orthop 2013; 37:839-42. 18. Patil PV, Chanchpara G, Gunaki RB, Gaonkar K, Gaonkar N, Solanki M, et al. Platelet-rich plasma for plantar fasciitis: Is it a hype Int J Orthop Sci 2017;3:226-30. 19. Shetty N, Shetty V, Shetty S (2018) A Comparative Prospective Study of Platelet Rich Plasma vs. Corticosteroid Injection in Plantar Fasciitis not Responding to 6 Weeks of Conservative Treatment. Int J Foot Ankle 2018. 4. . Kukreja T, Agarwal T, Singh A, Bhugra H. Comparative study for the treatment of plantar fasciitis by corticosteroids versus platelet rich plasma. Med J DY Patil Univ 2017; 10:252-65. 21. Shetty SH, Dhond A, Arora M, Deore S. Platelet-Rich Plasma Has Better Long-Term Results Than Corticosteroids or Placebo for Chronic Plantar Fasciitis: Randomized Control Trial. J Foot Ankle Surg. 2019;58(1):42-46.